PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways

The PI3K/Akt/mTOR pathway has a central role in cancer metastasis and radiotherapy. To develop effective therapeutics to improve radiosensitivity, understanding the possible pathways of radioresistance involved and the effects of a combination of the PI3K/Akt/mTOR inhibitors with radiotherapy on pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, L, Graham, P H, Hao, J, Ni, J, Bucci, J, Cozzi, P J, Kearsley, J H, Li, Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237243/
https://www.ncbi.nlm.nih.gov/pubmed/25275598
http://dx.doi.org/10.1038/cddis.2014.415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237243/
https://www.ncbi.nlm.nih.gov/pubmed/25275598
http://dx.doi.org/10.1038/cddis.2014.415

Ejemplares similares